PDS Biotechnology Corporation
PDSB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $59 | $154 | $378 | $207 |
| - Cash | $42 | $57 | $74 | $65 |
| + Debt | $22 | $24 | $23 | $0 |
| Enterprise Value | $40 | $121 | $327 | $143 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$34 | -$40 | -$41 | -$21 |
| % Margin | – | – | – | – |
| Net Income | -$38 | -$43 | -$41 | -$17 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.03 | -1.39 | -1.43 | -0.66 |
| % Growth | 25.9% | 2.8% | -116.7% | – |
| Operating Cash Flow | -$35 | -$34 | -$26 | -$12 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$35 | -$34 | -$26 | -$12 |